Home > Insider Trading > Filing (0000014272-15-000046)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
14272	Bristol Myers Squibb Co	BMY	Pharmaceutical Preparations (2834)	220790350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1198959	M James Cornelius	Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	Disposition	2015-01-30	50,000	$60.60	119,464	No	4	S	Direct
Common Stock, $0.10 Par Value	Disposition	2015-01-30	40,000	$0.00	79,464	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	G	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.10 Par Value	Deferred Share Units	Acquisiton	2015-02-01	2,655	$60.27	2,655	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,914			No	4	A	Direct

Footnotes

The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $60.55 to $60.76, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.